Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice

Shigellosis is a diarrheal disease caused prevalently by <i>Shigella flexneri</i> and <i>S. sonnei</i> and representing a major global health risk, particularly in developing countries. Bacterial O-antigen (OAg) is the primary target of the host immune response and modificati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vanessa Arato, Davide Oldrini, Luisa Massai, Gianmarco Gasperini, Francesca Necchi, Francesca Micoli
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6c2d235a723a49bb93a91981c21a43de
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6c2d235a723a49bb93a91981c21a43de
record_format dspace
spelling oai:doaj.org-article:6c2d235a723a49bb93a91981c21a43de2021-11-25T18:25:25ZImpact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice10.3390/microorganisms91123602076-2607https://doaj.org/article/6c2d235a723a49bb93a91981c21a43de2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-2607/9/11/2360https://doaj.org/toc/2076-2607Shigellosis is a diarrheal disease caused prevalently by <i>Shigella flexneri</i> and <i>S. sonnei</i> and representing a major global health risk, particularly in developing countries. Bacterial O-antigen (OAg) is the primary target of the host immune response and modifications of its oligosaccharide units, including O-acetylation, are responsible for the variability among the circulating <i>S. flexneri</i> serotypes. No vaccines are widely available against shigellosis and the understanding of the immunogenicity induced by the OAg is fundamental for the design of a vaccine that could cover the most prevalent <i>Shigella</i> serotypes. To understand whether a different O-acetylation pattern could influence the immune response elicited by <i>S. flexneri</i> OAg, we employed as a vaccine technology GMMA purified from <i>S. flexneri</i> 2a and 1b strains that were easily engineered to obtain differently O-acetylated OAg. Resulting GMMA were tested in mice, demonstrating not only no major impact of O-acetyl decorations on the immune response elicited by the two OAg against the homologous strains, but also that the O-acetylation of the Rhamnose III residue (O-factor 9), shared among serotypes 1b, 2a and 6, does not induce cross-reactive antibodies against these serotypes. This work contributes to the optimization of vaccine design against <i>Shigella</i>, providing indication about the ability of shared epitopes to elicit broad protection against <i>S. flexneri</i> serotypes and supporting the identification of critical quality attributes of OAg-based vaccines.Vanessa AratoDavide OldriniLuisa MassaiGianmarco GasperiniFrancesca NecchiFrancesca MicoliMDPI AGarticle<i>Shigella flexneri</i>O-antigenO-acetylationGMMA vaccineBiology (General)QH301-705.5ENMicroorganisms, Vol 9, Iss 2360, p 2360 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>Shigella flexneri</i>
O-antigen
O-acetylation
GMMA vaccine
Biology (General)
QH301-705.5
spellingShingle <i>Shigella flexneri</i>
O-antigen
O-acetylation
GMMA vaccine
Biology (General)
QH301-705.5
Vanessa Arato
Davide Oldrini
Luisa Massai
Gianmarco Gasperini
Francesca Necchi
Francesca Micoli
Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
description Shigellosis is a diarrheal disease caused prevalently by <i>Shigella flexneri</i> and <i>S. sonnei</i> and representing a major global health risk, particularly in developing countries. Bacterial O-antigen (OAg) is the primary target of the host immune response and modifications of its oligosaccharide units, including O-acetylation, are responsible for the variability among the circulating <i>S. flexneri</i> serotypes. No vaccines are widely available against shigellosis and the understanding of the immunogenicity induced by the OAg is fundamental for the design of a vaccine that could cover the most prevalent <i>Shigella</i> serotypes. To understand whether a different O-acetylation pattern could influence the immune response elicited by <i>S. flexneri</i> OAg, we employed as a vaccine technology GMMA purified from <i>S. flexneri</i> 2a and 1b strains that were easily engineered to obtain differently O-acetylated OAg. Resulting GMMA were tested in mice, demonstrating not only no major impact of O-acetyl decorations on the immune response elicited by the two OAg against the homologous strains, but also that the O-acetylation of the Rhamnose III residue (O-factor 9), shared among serotypes 1b, 2a and 6, does not induce cross-reactive antibodies against these serotypes. This work contributes to the optimization of vaccine design against <i>Shigella</i>, providing indication about the ability of shared epitopes to elicit broad protection against <i>S. flexneri</i> serotypes and supporting the identification of critical quality attributes of OAg-based vaccines.
format article
author Vanessa Arato
Davide Oldrini
Luisa Massai
Gianmarco Gasperini
Francesca Necchi
Francesca Micoli
author_facet Vanessa Arato
Davide Oldrini
Luisa Massai
Gianmarco Gasperini
Francesca Necchi
Francesca Micoli
author_sort Vanessa Arato
title Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_short Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_full Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_fullStr Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_full_unstemmed Impact of O-Acetylation on <i>S. flexneri</i> 1b and 2a O-Antigen Immunogenicity in Mice
title_sort impact of o-acetylation on <i>s. flexneri</i> 1b and 2a o-antigen immunogenicity in mice
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6c2d235a723a49bb93a91981c21a43de
work_keys_str_mv AT vanessaarato impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT davideoldrini impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT luisamassai impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT gianmarcogasperini impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT francescanecchi impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
AT francescamicoli impactofoacetylationonisflexnerii1band2aoantigenimmunogenicityinmice
_version_ 1718411201922203648